Using cell line xenograft and patient-derived models in mice, our data indicate that the radio-labelled antibody agent, 89Zr-10D7, directed against the receptor CDCP1, can be employed in PET-CT imaging to detect CRC in vivo. This evidence concerns the gene CDCP1 and colorectal carcinoma.